CMPX FY 2024 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CMPXCompass Therapeutics, Inc.

$781M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$850,000

Gross Profit

$850,000100.0% margin

Operating Income

-$57M-6661.8% margin

Net Income

-$49M-5808.8% margin

EPS (Diluted)

$-0.36

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$140M

Total Liabilities

$15M

Stockholders' Equity

$125M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$850,000	$0	—
Gross Profit	$850,000	$0	—
Operating Income	-$57M	-$50M	-12.4%
Net Income	-$49M	-$42M	-16.2%